Skip to content
Menu

Alpha Teknova, Inc. TKNO

Full chart Compare
Set alert

Price alert · TKNO

All alert types
7.81 USD -0.07 (-0.89%)

Regular-session close

7.81 0.00 0.00%

After hours · Nov 19, 4:27 PM ET

7.69 Day range 8.12
1.91 52-week range 9.48
YTD
+105.53%
1 year
+76.70%

5D -0.25 (-3.06%)

7.607.8088.20FriMonTueWedThu7.92
Market cap
491.27M
Revenue (ttm)
36.35M
Profit margin
-87.17%
EPS (ttm)
-0.30
Shares out
53.31M
Forward P/E
-19.69
YTD return
+105.53%
1-year return
+76.70%
50-day average
7.11
Volume
266.84K
Avg volume
437.87K
Open
7.93
Previous close
7.88
Day's range
7.69 – 8.12
52-week range
1.91 – 9.48
Beta
0.36
Analysts
Buy
Price target
8.00 (+2.4%)

Key statistics

200-day average
3.96
Enterprise value
399.47M
Price / sales
11.26
Price / book
4.56
Revenue growth
17.20%
Free cash flow
-4.99M
Total cash
31.69M
Total debt
30.59M
Return on equity
-33.90%
Short % of float
1.33%

Fundamental scorecard

7 of 25 checks passed on TKNO’s reported financials

ValueGrowthProfitabilityHealthDividend

7of 25 checks passed

  • Value 0 of 5
  • Growth 3 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
TKNO Revenue — quarterly 12.70M
TKNO Net income — quarterly -3.49M
TKNO EPS — quarterly -0.06

Earnings

TKNO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 20240.00-0.15——
Aug 13, 2024Jun 1, 20240.00-0.13——
Aug 13, 2024Jun 1, 20240.00———
May 13, 2024Mar 1, 20240.00-0.20——
May 13, 2024Mar 1, 20240.00———
Mar 11, 2024Dec 1, 2023-0.23-0.22+0.01+4.35%

Upgrades / downgrades

TKNO analyst upgrades and downgrades
DateFirmActionFromTo
Jul 10, 2024Stephens & Co.reitOverweightOverweight
May 14, 2024Stephens & Co.reitOverweightOverweight
Mar 12, 2024BTIGdownBuyNeutral
Jul 12, 2023Keybancinit—Sector Weight
Aug 11, 2022Stephens & Co.main—Overweight
Mar 16, 2022Stephens & Co.main—Overweight

About Alpha Teknova, Inc.

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Website
teknova.com

News

Your note

Sign in to keep a note on TKNO — it syncs with the Stock Master app.

Insider holders

TKNO insider holders
InsiderRelationLatest transactionDateShares held
DEMSKI MARTHA J.DirectorStock Award(Grant)Jun 25, 202420,000
GELHAUS KENOfficerPurchaseNov 29, 202322,924
GUNSTREAM STEPHENChief Executive OfficerPurchaseJul 11, 2024243,497
HOOD LISAOfficerSaleJun 12, 202333,834
LOWELL MATTHEWChief Financial OfficerPurchaseJul 11, 2024128,376
MACKOWSKI J MATTHEWDirectorPurchaseSep 18, 20230

Institution ownership

TKNO institution ownership
Holder% heldSharesValueReported
Balyasny Asset Management LLC1.88%1,000,0907.68MSep 29, 2024
Millennium Management Llc1.38%737,2155.66MSep 29, 2024
Vanguard Group Inc1.05%560,8604.31MSep 29, 2024
Roubaix Capital, LLC0.78%416,4163.20MSep 29, 2024
Schonfeld Strategic Advisors Llc0.69%366,4002.81MSep 29, 2024
Conestoga Capital Advisors, LLC0.57%305,1292.34MSep 29, 2024

Fund ownership

TKNO fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund0.57%303,0472.33MSep 29, 2024
Vanguard Extended Market Index Fund0.45%240,6291.85MSep 29, 2024
Bridgeway Funds Inc-Ultra Small Company Market Fund0.21%110,000844.80KSep 29, 2024
Fidelity Extended Market Index Fund0.14%75,363578.79KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.09%47,379363.87KOct 30, 2024
Conestoga Discovery Fund0.06%30,716235.90KSep 29, 2024